Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00463047 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
A Phase 3 study, sponsored by Cephalon.
- Completed
- Registry status
- Phase 3
- Development phase
- 323
- Enrollment target
NCT00463047 is a Phase 3 study that has completed, run by Cephalon. The registered enrollment target is 323 participants.
The verdict
NCT00463047, a Phase 3 study, has completed, sponsored by Cephalon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 323 participants
- Enrollment target
Study Summary
Evaluate the efficacy of treatment with Fentanyl Buccal Tablets (FBT) compared with immediate release oxycodone in alleviating breakthrough pain in opioid tolerant patients with chronic pain.
Interventions
- DRUG Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00463047
The ClinicalTrials.gov registry entry for NCT00463047 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cephalon, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone is the first listed.
NCT00463047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00463047 about?
NCT00463047 is a clinical study titled "Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain". Evaluate the efficacy of treatment with Fentanyl Buccal Tablets (FBT) compared with immediate release oxycodone in alleviating breakthrough pain in opioid tolerant patients with chronic pain.
What is the current status of trial NCT00463047?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 323 participants. The study started on 2007-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00463047?
The interventions under investigation include: Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone (DRUG).
Who is sponsoring clinical trial NCT00463047?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.